Thanksfor reaching out to him, it's all you can do really.
To be honest, his article shows he pretty much has his mind made up and soundslike it would be hard for him to back away from his own conclusions now.
While googling his article, I did find this other article, which has interesting commentaryabout Adequan vs Legend vs Pentosan for horses.
https://www.equisearch.com/discoverhorses/adequan-legend-pentosan-16151
They appear to have a favourable opinion of the new guy "Pentosan"
Quote from article "Some studies have found it to be 10 times as potent as other joint supplements in stopping inflammatory mediator releases. But, you may ask, do these laboratory observations transfer over into the real world and to horses? Yes!"
MOZZ Research - First Half 2021, page-46
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.005(2.13%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.5¢ | 23.0¢ | $37.24K | 157.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5184 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 34937 | 7 |
View Market Depth
| Last trade - 13.33pm 10/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |